Revenue
2020
2021
2022
2023
2024
2025
Healthcare Triangle, Inc. (HCTI)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2022
2023
2025
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $13.9M | $11.7M | $33.2M | $45.9M | $35.3M | $31.3M |
| Gross profit | $1.24B | $1.07B | $1.07B | — | — | — |
| Research & development | $536,000 | $429,000 | $799,000 | $8.1M | $5.3M | $1.7M |
| Operating expenses | $11.7M | $7.6M | $14.5M | $27.6M | $15.9M | — |
| Operating income | −$9.8M | −$4.8M | −$7.7M | −$16.3M | −$5.4M | $1.2M |
| EBITDAderived | −$9.1M | −$3.9M | −$6.1M | −$13.4M | −$3.9M | $2.0M |
| Net income | −$9.5M | −$6.0M | −$8.7M | −$14.4M | −$5.9M | $2.4M |
| Basic EPSper diluted share | -$152.30 | -$16,909.30 | -$2.08 | -$3.88 | -$0.20 | $0.08 |
| Diluted EPSper diluted share | -$152.30 | -$16,909.30 | -$2.08 | -$3.88 | -$0.20 | $0.08 |